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Abstract Ca 2+ entry is a prerequisite for both exocytosis and the phosphorylation f synapsin I and MARCKS proteins in mammalian cerebrocor- 
tical synaptosomes. The novel spider toxin Aga-GI completely blocks KCl-evoked glutamate exocytosis but only partially inhibits KCl-evoked 
cytoplasmic Ca 2+ elevations, thus revealing at least wo pathways for KCl-induced Ca 2+ entry. Aga-GI completely attenuates KCl-induced phospho- 
rylation of synapsin I and MARCKS proteins. We therefore conclude that both exocytosis and the phosphorylation f synapsin I and MARCKS 
proteins are specifically coupled to Ca 2+ entry via a subset of voltage dependent Ca 2+ channels at the nerve terminal which are sensitive to Aga-GI. 
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1. Introduction 
Glutamate xocytosis from mammalian CNS nerve terminals 
is dependent on localized Ca 2+ influx through voltage depend- 
ent Ca 2+ channels [1-3]. We have isolated a novel spider toxin, 
Aga-GI, and established that the Ca 2÷ trigger mediating luta- 
mate exocytosis from mammalian cerebrocortical synap- 
tosomes occurs via voltage dependent Ca 2÷ channels ensitive 
to Aga-GI, and not via L- or N-type voltage dependent Ca 2÷ 
channels [4,5]. The action of Aga-GI is distinct from 09Aga-IVA 
in that Aga-GI can completely inhibit glutamate xocytosis 
under stimulatory conditions which optimize release [6,7]. 
However, at a concentration of Aga-GI which completely 
blocks KCl-evoked glutamate exocytosis, only a partial inhibi- 
tion of KCl-evoked cytoplasmic free Ca 2÷ elevation, [Ca2+]c, is 
observed [4]. 
In addition to triggering exocytosis, [8,9], Ca 2+ initiates many 
events associated with secretion in nerve terminals including 
cytoskeletal disassembly [10] and protein phosphorylation/ 
dephosphorylation [3,11-13]. The relationship between protein 
phosphorylation and exocytotic events in nerve terminals is 
actively debated [14--18]. The neuron-specific synapsins I and 
II are localized almost exclusively in regions of the nerve termi- 
nal occupied by synaptic vesicles [19,20]. Depolarization- 
evoked Ca 2÷ entry activates Ca2+-calmodulin-dependent pro- 
tein kinase II (CaMKII) leading to phosphorylation of the 
C terminal of synapsin I [21,22] and this has been proposed to 
facilitate dissociation of synaptic vesicles from the actin cy- 
toskeleton, thus increasing their availability for exocytosis 
[17,23]. Protein kinase C (PKC) dependent phosphorylation f 
MARCKS (myristoylated alanine rich C kinase substrate) 
[13,24,25] is also enhanced by depolarization-stimulated Ca 2÷ 
entry [26]. 
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Thus Ca2÷-activated kinases instigate a sequence of phospho- 
rylation events which occur in parallel with exocytosis. The ion 
channel responsible for gating the Ca 2÷ influx coupled to phos- 
phorylation has not been identified although recently it has 
been shown that Ca 2÷ influx via L- or N-type voltage dependent 
Ca 2÷ channels does not support the phosphorylation of 
MARCKS in hippocampal s ices [27]. 
Here we ask whether depolarization-evoked Ca 2÷ influx via 
the subset of Aga-GI sensitive Ca 2÷ channels, which are inti- 
mately coupled to glutamate xocytosis [4], is also responsible 
for the phosphorylation of synapsin I and MARCKS, or 
whether the portion of the KCl-evoked [Ca2+]¢ elevation ot 
blocked by the toxin and not coupled to release is responsible 
for synapsin I and MARCKS phosphorylation. 
2. Materials and methods 
2.1. Materials 
Glutamate dehydrogenase (E.C. 1.4.1.3) was from Sigma Chemical 
Co. (Poole, UK). The enzyme was dialyzed under pressure to remove 
contaminating glutamate. Fura-2 acetoxymethylester was fromCalbio- 
chem Novabiochem (Nottingham, UK). 32p was from Amersham Inter- 
national, Amersham, UK. Agelenopsis aperta venom was obtained 
from Spider Pharm, Feasterville, USA and Aga-GI purified as previ- 
ously described [4]. Omega-conotoxin GVIA (oK~gTx GVIA) was ob- 
tained from RBI Research Biochemicals Inc, Semat Technical, UK. All 
other eagents were f om Sigma Chemical Co. and BDH Laboratory 
Supplies (Poole, UK). 
2.2. Synaptosomal preparation 
Synaptosomes from the cerebrocortices of 6 week old male Wistar 
rats were purified as described by [28], with minor modifications [13]. 
Protein was determined bythe Bradford method [29]. The final synap- 
tosomal pellet was resuspended in 'HEPES-buffered medium' (HBM) 
consisting of 140 mM NaC1, 5 mM KC1, 5 mM NaHCO3, I mM MgC12, 
10 mM glucose, 10 mM HEPES and 1.2 mM NaH2PO4 (pH 7.4). 
2.3. Glutamate release 
Glutamate release was ssayed by on-line fluorimetry as described 
previously [6]. Synaptosomal pellets (0.25 mg protein/ml) were incu- 
bated in HBM at 37"C in the presence of NADP + (1 mM), glutamate 
dehydrogenase (50 units/ml) and CaC12 (1 mM). After 10 min at 37°C, 
synaptosomes were depolarized by the addition of 30 mM KC1. Aga-GI 
(500 nM final concentration) was added 30 s prior to depolarization 
where indicated. Fluorescence was monitored ina Perkin-Elmer LS5B 
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spectrofluorometer at 340 nm (excitation) and 460 nm (emission), and 
data were accumulated at 2 s intervals. A standard of exogenous gluta- 
mate (2.5 nmol) was added at the end of each experiment. The value 
of the fluorescence change produced by the standard addition was used 
to calculate the released glutamate as nmol glutamate release/mg of 
synaptosomal protein. 
2.4. Cytosolic Cc~* measurements 
Synaptosomes (0.25 mg/ml) were incubated in HBM as described 
above. At 5 min, 0.1 mM CaC12 and 5 pM fura-2-aeetoxymethyl ester 
were added; at 30 rain, the synaptosomes were centrifuged ina micro- 
fuge for 15 s and resuspended in fresh HBM. CaC12 (1 mM) was added 
after 5 rain, and further additions were made as detailed in the legends 
to figures. Fluorescence data were accumulated at excitation wave- 
lengths of 340 and 380 nm with an emission wavelength of 505 nm at 
intervals of 3.4 s. Cytoplasmic free Ca 2÷, [Ca2÷]c, was calculated accord- 
ing to [30]. 
2.5. Synaptosomal phosphorylation 
Synaptosomes (0.5 mg/ml) were prelabelled with [32p]orthophosphate 
(1 mCi/mg) for 60 rain in phosphate free HBM. Extra-synaptosomal 
[32p]orthophosphate was removed by centrifugation of the synap- 
tosomes in a microfuge at 10,000 xg~ for 15 s. Synaptosomes were 
then resuspended to 0.5 mg/ml in HBM + phosphate and incubated for 
10 min at 37°C in the presence of CaCI2 (1 mM). 
The labeled synaptosomes were incubated with Aga-GI (500 riM) or 
control buffer for 30 s prior to depolarization with 30 mM KCI as 
indicated in the legends. The final synaptosomal protein co centration 
was 0.3 mg/ml. Incubations were stopped by the addition of stop buffer 
to give a final concentration f 1% SDS, 6.25 mM Tris (pH 6.8), 5% 
(v/v) 2-mercaptoethanol, 10% (v/v) glycerol and 0.001% Bromopbenol 
blue. Samples were boiled for 10 min and run on 7.5% SDS poly- 
acrylamide gels. Gels were stained with Coomassie blue and destained. 
Where appropriate, the 75 kDa band containing both the MARCKS 
protein and the synapsins was excised from the wet gel, proteolyzed 
with Staphylococcus aureus V8 protease and rerun on a 15% SDS- 
polyacrylamide gel according to Wang and Greengard 1988, [13]. 
32p-labeled proteins were visualized by autoradiography or phosphori- 
maging (for the proteolytic fragments). Radioactivity in the latter was 
quantified by scanning the phosphorimages using a Molecular Dynam- 
ics program (Sunnyvale, CA, USA). 
3. R ~  
At a concentration of 500 nM, Aga-GI totally inhibits he 
Ca2*-dependent KCI evoked glutamate release from rat cere- 
brocortical synaptosomes (Fig. 1A). This is the first report hat 
this toxin is able to block glutamate release from nerve endings 
derived from rat brain; previous reports have shown this toxin 
blocks exocytosis from guinea pig cerebrocortical synap- 
tosomes [4]. At the same concentration, Aga-GI blocks 
48.15 + 1.26% of the KCl-evoked [Ca2+]o elevation whether 
added before or after KCI (Fig. 1B). It should be noted that it 
is the plateau component of the fura-2 response which is cou- 
pled to glutamate exocytosis [1]. The Ca 2+ elevation induced by 
the Ca 2+ ionophore ionomycin is not blocked by Aga-GI (Fig. 
1B); this is consistent with the locus of action of the toxin being 
at a voltage-dependent Ca 2+ channel. These results resolve the 
KCl-evoked Ca 2* influx into two components; an Aga-GI sen- 
sitive component coupled to glutamate xocytosis and an Aga- 
GI  insensitive component which is not coupled to release. 
Fig. 2A shows a representative 7.5% SDS-polyacrylamide g l 
electrophoresis depicting the influence of KC1 and Aga-GI on 
the phosphorylation profile of rat cerebrocortical synap- 
tosomal proteins. It is qualitatively evident that the depolariza- 
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Fig. 1. Aga-GI blocks KCl-evoked glutamate exocytosis and [Ca*]~ elevations in rat cerebrocortical synaptosomes. (A) Glutamate r lease, assayed 
by on-line fluorimetry, was evoked by the addition of 30 mM KC1 in the presence of 1 mM Ca 2+ (Ca2+/KC1 control) or absence of external Ca 2+ 
(-Ca2+/KC1 control). Preincubation with 500 nM Aga-GI for 30 s before KCI addition in the presence of 1 mM Ca 2÷ inhibited glutamate rel ase 
to that produced in the absence of Ca 2+. Data are the means of 3 replicates __S.E.M. (bar to side of each trace). (B) Increased [Ca:+]~ following 30 
mM KC1 stimulation was assessed with fura-2. 500 nM Aga-GI added before KC1 (i) or after (ii) attenuated a maximum of 48% of the plateau [Ca2÷]~ 
elevation. 0.25 pM ionomycin-induced [Ca2+]c elevations are not attenuated byAga-GI (iii). Data are the means of 3 replicates _+ S.E.M. (bar to side 
of each trace). 
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Fig. 2. Phosphorylation profile of rat cerebrocortical synaptosomal proteins on depolarization with KC1 + Aga-GI. (A) A representative autoradi- 
ogram of synaptosomal phosphoproteins following 7.5% polyacrylamide gel elec~rophoresis of 32P-prelabeled synaptosomes incubated in the presence 
of 30 mM KCI, 1 mM Ca 2+ + 500 nM Aga-GI. Aga-GI and KC1 were added 45 s and 15 s respectively prior to quenching. (B) A representative 
autoradiogram ofphosphopeptides contained in the 75 kDa MARCKS/synapsin I band excised from a 7.5% polyacrylamide gel processed according 
to (A), digested with limited S. aureus V8 protease treatment and separated on a 15% polyacrylamide gel. This allows quantification of the 35kDa 
and 10 kDa synapsin I peptides and the 13 kDa MARCKS protein. 
tion-evoked Ca2÷-dependent phosphorylation of a number of 
proteins is inhibited by prior treatment with Aga-GI. In partic- 
ular, Aga-GI inhibits the phosphorylation of a group of 
phosphoproteins migrating as a 75 kDa band on SDS-PAGE. 
Since synapsins I and II, and MARCKS are contained in this 
group, this broad band was further dissected by limited prote- 
olysis as described in section 2. Three major bands were ob- 
tained by this treatment (Fig. 2B) which have been shown to 
correspond, respectively, toa 35 kDa peptide ncompassing the 
two CaMK phosphorylation sites of synapsin I, a 13 kDa 
MARCKS-derived peptide and a 10 kDa band which is a com- 
posite of a MARCKS peptide and the PKA/CaMKI site of 
synapsin I [13]. 
The data from multiple replicate phosphorylation experi- 
ments are expressed quantitatively in Fig. 3. It is clear that 
depolarization-enhanced phosphorylation of MARCKS and 
synapsin I is totally inhibited. The toxin also inhibited epolar- 
ization-enhanced phosphorylation of synapsin 35 kDa and 
10 kDa proteins from guinea pig cerebrocortical synaptosomes 
to 1.43 + 27.14% and 17.91 + 14.93% of control KCl-induced 
phosphorylation. This in turn implies that the kinases responsi- 
ble for the phosphorylation f MARCKS, i.e. PKC, and syn- 
apsin I (Ca2÷-calmodulin-dependent protein kinase I, CaMKII 
and protein kinase A [17] are not activated in the presence of 
the toxin. The L-type voltage dependent Ca 2÷ channel antago- 
nist, nifedipine (1 pM), the N-type voltage dependent Ca 2÷ 
channel antagonist coCgTx GVIA (1/zM), and the P-type volt- 
age dependent Ca 2÷ channel antagonist coAgalVA had no sig- 
nificant effects on synapsin I and MARCKS phosphorylation 
following KC1 stimulation (data not shown). 
4. D iscuss ion  
At a concentration f500 nM, Aga-GI completely attenuates 
glutamate xocytosis from rat cerebrocortical synaptosomes 
but only blocks a maximum of 48% of the plateau KCl-evoked 
[Ca2+]c elevation. The toxin also completely blocks the KC1- 
evoked phosphorylation f synapsin and MARCKS proteins. 
The total inhibition of phosphorylation i  the presence of 
Aga-GI is not due to a reduction of the bulk cytoplasmic free 
Ca 2÷ concentration below a critical threshold for activation of 
the kinases. Thus suboptimal depolarization ofrat cortical syn- 
aptosomes with 10 mM KC1, sufficient to cause a 60% decrease 
in the maximal release of glutamate and a similar decrease in 
the fura-2 plateau, still allows a proportionate phosphorylation 
of the MARCKS/synapsin band to be observed [3]. This in turn 
amplifies the previous conclusion [3], that the pathway of Ca 2÷ 
entry is critical for the phosphorylation f these proteins. 
While structural data on presynaptic Ca 2÷ channels are al- 
most non-existent, pharmacological studies uggest that multi- 
ple channel sub-types might co-exist on individual terminals to 
control Ca 2+ entry [31], and neurotransmitter r lease [7,32-34]. 
Under the present conditions of stimulation, no modulation of 
glutamate release is observed with L, N or P type voltage 
dependent Ca 2+ channel antagonists [4,7]. Thus the channel 
coupled to release and kinase activation is a specific subtype 
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Fig. 3. Aga-GI blocks the depolarization evoked phosphorylation f synapsin I and MARCKS Meaned data of replicate xperiments performed 
as described in Fig. 2A,B depicting the 35 kDa and 10 kDa Ca2÷/calmodulin (CaMKI and II) and PKA phosphorylated synapsin I peptides and the 
13 kDa PKC phosphorylated MARCKS peptide are shown. Data are expressed as a percent of the control phosphorylation obtained in the absence 
of a KCI stimulus (n = 3 + S.E.M.). 
which can be blocked by Aga-GI. Ca 2÷ influx via L- or N-type 
voltage dependent Ca 2+ channels failed to influence the phos- 
phorylation of MARCKS in hippocampal s ices [27]. Since P- 
and N-type channels in hippocampal s ices are able to modulate 
glutamate xocytosis [34], it is of interest hat ogCgTx GVIA 
had no effect on phosphorylation events. 
The complete block by Aga-GI of the KCl-evoked glutamate 
exocytosis and the phosphorylation events described above 
suggests that there is a tight coupling between Ca 2÷ entry via 
this channel and the phosphorylation of synapsin I and 
MARCKS.  This may be a result of either colocalization of 
synapsin I and MARCKS proteins with Aga-GI sensitive Ca 2+ 
channels, or colocalization of synapsin I and MARCKS spe- 
cific Ca 2÷ dependent kinases with these Ca 2+ channels. 
This is the first report to identify a specific voltage-dependent 
Ca 2+ channel which modulates both glutamate xocytosis and 
the phosphorylation f synapsin I and MARCKS. Although we 
have shown that phosphorylation events which occur in cere- 
brocortical synaptosomes are not a primary requirement for 
KCl-stimulated glutamate exocytosis [16,35,36], recent evi- 
dence suggests a modulatory role for synapsins in synaptogene- 
sis [37] or short term plasticity [38]. 
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